Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study

OBJECTIVE: Despite the demonstrated benefits of glucagon-like peptide 1 (GLP-1) receptor agonist therapy, adherence and persistence with this therapy is often challenging. The purpose of this study was to expand current understanding of patients’ experiences, motivations, and challenges relevant to...

Descripción completa

Detalles Bibliográficos
Autores principales: Polonsky, William, Gamble, Cory, Iyer, Neeraj, Martin, Mona, Hamersky, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178715/
https://www.ncbi.nlm.nih.gov/pubmed/34149258
http://dx.doi.org/10.2337/ds20-0025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178715/
https://www.ncbi.nlm.nih.gov/pubmed/34149258
http://dx.doi.org/10.2337/ds20-0025

Ejemplares similares